🔥🐔 BizChicken 🐔🔥

Companies Similar to Petros Pharmaceuticals, Inc.

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

Allarity Therapeutics, Inc.

Allarity Therapeutics, Inc. logo
Market Cap: Lowest
Employees: Lowest

Stenoparib, Dovitinib, IXEMPRA, Li Pla Cis, 2X-111

Allarity Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing oncology therapeutics using companion diagnostics and drug response predictor technology.

Tags: biopharmaceutical, clinical trials, companion diagnostics, oncology, therapeutics

Symbol: ALLR

Recent Price: $1.12

Industry: Biotechnology

CEO: Mr. Thomas H. Jensen

Sector: Healthcare

Employees: 5

Address: 210 Broadway, Cambridge, MA 02139

Phone: 401 426 4664

Last updated: 2024-12-31

Protagonist Therapeutics, Inc.

Protagonist Therapeutics, Inc. logo
Market Cap: High
Employees: Low

rusfertide (PTG-300), PN-943, PN-235

Protagonist Therapeutics, Inc. is a biopharmaceutical company that focuses on the discovery and development of peptide-based therapeutic drugs for hematology, blood disorders, and inflammatory and immunomodulatory diseases.

Tags: biopharmaceutical, blood disorders, hematology, immunomodulatory diseases, inflammatory diseases, peptide-based drugs

Symbol: PTGX

Recent Price: $38.51

Industry: Biotechnology

CEO: Dr. Dinesh V. Patel Ph.D.

Sector: Healthcare

Employees: 125

Address: 7707 Gateway Boulevard, Newark, CA 94560-1160

Phone: 510 474 0170

Last updated: 2024-12-31

Statera Biopharma, Inc.

Statera Biopharma, Inc. logo
Market Cap: Lowest
Employees: Lowest

STAT-201, Entolimod, STAT-401, STAT-205

Statera Bio Pharma, Inc. is a clinical-stage biopharmaceutical company focused on developing novel immunotherapies to treat autoimmune diseases, cancers, and infectious diseases by rebalancing the immune system.

Tags: autoimmune, biopharmaceutical, cancer, immune system, immunotherapy, infectious diseases, novel therapies

Symbol: STAB

Recent Price: $0.00

Industry: Biotechnology

CEO: Mr. Michael Kevin Handley

Sector: Healthcare

Employees: 46

Address: 2537 Research Boulevard, Fort Collins, CO 80526

Phone: 888 613 8802

Last updated: 2024-12-31

Vaccinex, Inc.

Vaccinex, Inc. logo
Market Cap: Lowest
Employees: Lowest

pepinemab

Vaccinex, Inc., a clinical-stage biotechnology company, focuses on developing targeted biotherapeutics for cancer, neurodegenerative diseases, and autoimmune disorders. Its lead product candidate, pepinemab, is in clinical trials for multiple serious conditions.

Tags: autoimmune disorders, biotechnology, biotherapeutics, cancer, clinical trials, neurodegenerative diseases

Symbol: VCNX

Recent Price: $1.11

Industry: Biotechnology

CEO: Dr. Maurice Zauderer Ph.D.

Sector: Healthcare

Employees: 37

Address: 1895 Mount Hope Avenue, Rochester, NY 14620

Phone: 585 271 2700

Last updated: 2024-12-31

Glaukos Corporation

Glaukos Corporation logo
Market Cap: Highest
Employees: Medium

i Stent, i Stent inject, i Stent inject W, i Stent Infinite, i Dose TR

Glaukos Corporation is a medical technology and pharmaceutical company developing therapies for glaucoma, corneal disorders, and retinal diseases. It offers micro-bypass stents and injectable implants intended to improve intraocular treatment.

Tags: corneal disorders, glaucoma treatment, i Dose TR, i Stent, medical technology, ophthalmic, pharmaceutical, retinal diseases

Symbol: GKOS

Recent Price: $149.51

Industry: Medical - Devices

CEO: Mr. Thomas William Burns

Sector: Healthcare

Employees: 907

Address: 229 Avenida Fabricante, San Clemente, CA 92672

Phone: 949 367 9600

Last updated: 2024-12-31

Pfizer Inc.

Pfizer Inc. logo
Market Cap: Highest
Employees: Highest

biopharmaceutical products

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide, offering medicines and vaccines across various therapeutic areas.

Tags: COVID-19, biopharmaceuticals, biosimilars, medicines, therapeutic areas, vaccines

Symbol: PFE

Recent Price: $26.42

Industry: Drug Manufacturers - General

CEO: Dr. Albert Bourla D.V.M., Ph.D.

Sector: Healthcare

Employees: 88000

Address: 235 East 42nd Street, New York, NY 10017

Phone: 212 733 2323

Last updated: 2024-12-31

Arvinas, Inc.

Arvinas, Inc. logo
Market Cap: High
Employees: Medium

Bavdegalutamide, ARV-471, ARV-766

Arvinas, Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of therapies to degrade disease-causing proteins. The company is based in New Haven, Connecticut and collaborates with organizations like Pfizer Inc., Genentech, Inc., F. Hoffman-La Roche Ltd., and Bayer AG.

Tags: PROTAC, biopharmaceutical, cancer therapy, clinical-stage, protein degrader

Symbol: ARVN

Recent Price: $19.00

Industry: Biotechnology

CEO: Dr. John G. Houston Ph.D.

Sector: Healthcare

Employees: 445

Address: 5 Science Park, New Haven, CT 06511

Phone: 203 535 1456

Leadership

  • John G. Houston, Ph.D., Chairperson, Chief Executive Officer, and President
  • Noah Berkowitz, M.D., Ph.D., Chief Medical Officer
  • Angela M. Cacace, Ph.D., Chief Scientific Officer
  • Jared Freedberg, J.D., General Counsel and Corporate Secretary
  • Paul McInulty, Senior Vice President, Regulatory Affairs
  • John Northcott, Chief Commercial Officer
  • Kelly Page, Senior Vice President, Global Head of Oncology Strategy and Program Leadership
  • Andrew Saik, Chief Financial Officer
  • Lisa Sinclair, Senior Vice President, Corporate Operations
  • Ian Taylor, Ph.D., President, R&D
  • Randy Teel, Ph.D., Chief Business Officer
  • Steve Weiss, Senior Vice President, Chief Human Resources Officer

Last updated: 2024-12-31

Astria Therapeutics, Inc.

Astria Therapeutics, Inc. logo
Market Cap: Medium
Employees: Lowest

STAR-0215

Astria Therapeutics, Inc., is a biopharmaceutical company that focuses on the discovery, development, and commercialization of therapeutics for rare and niche allergic and immunological diseases in the United States. Its lead product candidate, STAR-0215, is targeting hereditary angioedema.

Tags: allergic diseases, biopharmaceutical, hereditary angioedema, immunological diseases, rare diseases

Symbol: ATXS

Recent Price: $8.88

Industry: Biotechnology

CEO: Ms. Jill C. Milne Ph.D.

Sector: Healthcare

Employees: 59

Address: 100 High Street, Boston, MA 02110

Phone: 617 349 1971

Last updated: 2024-12-31

89bio, Inc.

89bio, Inc. logo
Market Cap: Medium
Employees: Low

pegozafermin

89bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for liver and cardio-metabolic diseases, primarily through its lead product candidate, pegozafermin, designed to treat nonalcoholic steatohepatitis and severe hypertriglyceridemia.

Tags: biopharmaceutical, cardio-metabolic, clinical-stage, hypertriglyceridemia, liver diseases, nonalcoholic steatohepatitis, pegozafermin

Symbol: ETNB

Recent Price: $7.87

Industry: Biotechnology

CEO: Mr. Rohan Palekar

Sector: Healthcare

Employees: 70

Address: 142 Sansome Street, San Francisco, CA 94104

Phone: 415 432 9270

Last updated: 2024-12-31

PDS Biotechnology Corporation

PDS Biotechnology Corporation logo
Market Cap: Low
Employees: Lowest

PDS0101

PDS Biotechnology Corporation is a clinical-stage biopharmaceutical company focused on developing multifunctional cancer immunotherapies. Its lead product candidate, PDS0101, is in Phase II clinical trial for treating various human papillomavirus-associated malignancies.

Tags: biopharmaceutical, cancer immunotherapies, clinical trials, clinical-stage, oncology, vaccines

Symbol: PDSB

Recent Price: $1.69

Industry: Biotechnology

CEO: Dr. Frank K. Bedu-Addo Ph.D.

Sector: Healthcare

Employees: 25

Address: 25B Vreeland Road, Florham Park, NJ 07932

Phone: 800 208 3343

Leadership

  • Frank Bedu-Addo, Ph.D., Chief Executive Officer, Director
  • Stephan Toutain, Chief Operating Officer
  • Lars Boesgaard, Chief Financial Officer
  • Gregory Conn, Ph.D., Chief Scientific Officer
  • Kirk Shepard, M.D., Chief Medical Officer
  • Spencer Brown, Senior Vice-President, General Counsel, Corporate Secretary and Compliance Officer
  • Rory Cullinane, Vice President of Quality
  • Joe Dervan, Ph.D., Vice President of Research and Development
  • David Schaaf, M.D., Vice President of Medical Affairs
  • Sir Richard Sykes, Director
  • Ilian Iliev, Ph.D., Director
  • Gregory Freitag, J.D., CPA, Director
  • Otis W. Brawley, M.D., Director
  • Kamil Ali-Jackson, J.D., Director
  • Stephen Glover, Chairman

Last updated: 2024-12-31

PetMed Express, Inc.

PetMed Express, Inc. logo
Market Cap: Low
Employees: Low

Pet Medications and Supplies

Pet Med Express, Inc., operates as a pet pharmacy in the United States, marketing prescription and non-prescription pet medications, health products, and other supplies for pets through various channels including internet and telephone.

Tags: Animal Health, Non-Prescription Medications, Pet Medications, Pet Pharmacy, Pet Supplies, Prescription Medications

Symbol: PETS

Recent Price: $5.00

Industry: Medical - Pharmaceuticals

CEO: Ms. Sandra Y. Campos

Sector: Healthcare

Employees: 287

Address: 420 South Congress Avenue, Delray Beach, FL 33445

Phone: 561 526 4444

Last updated: 2024-12-31

Poseida Therapeutics, Inc.

Poseida Therapeutics, Inc. logo
Market Cap: Low
Employees: Medium

P-PSMA-101

Poseida Therapeutics, Inc. is a clinical-stage biopharmaceutical company focusing on developing innovative CAR-T therapies for patients with high unmet medical needs, including treatments for prostate cancer, multiple myeloma, and various solid tumors.

Tags: CAR-T therapy, biopharmaceutical, cancer treatment, clinical-stage, innovative therapeutics

Symbol: PSTX

Recent Price: $9.48

Industry: Biotechnology

CEO: Dr. Kristin Yarema Ph.D.

Sector: Healthcare

Employees: 337

Address: 9390 Towne Centre Drive, San Diego, CA 92121

Phone: 858 779 3100

Last updated: 2024-12-31

PTC Therapeutics, Inc.

PTC Therapeutics, Inc. logo
Market Cap: High
Employees: Medium

Translarna, Emflaza, Tegsedi, Waylivra, Evrysdi

PTC Therapeutics, Inc. is a biopharmaceutical company dedicated to discovering, developing, and commercializing medicines for patients with rare disorders. The company offers a portfolio of products including treatments for Duchenne muscular dystrophy, rare diseases, and spinal muscular atrophy.

Tags: Duchenne muscular dystrophy, biopharmaceutical, medicine development, rare disorders, spinal muscular atrophy

Symbol: PTCT

Recent Price: $45.77

Industry: Biotechnology

CEO: Dr. Matthew B. Klein F.A.C.S., M.D., M.S.

Sector: Healthcare

Employees: 988

Address: 100 Corporate Court, South Plainfield, NJ 07080

Phone: 908 222 7000

Leadership

  • Matthew B. Klein, M.D., M.S., F.A.C.S., CEO, PTC Therapeutics, Inc.
  • Neil Almstead, Ph.D., Chief Technical Operations Officer
  • John Baird, Ph.D., Chief of Staff to the CEO
  • Mark E. Boulding, Executive Vice President and Chief Legal Officer
  • Lee Golden, M.D., Chief Medical Officer
  • Pierre Gravier, Chief Financial Officer
  • Mary Frances Harmon, Senior Vice President, Corporate and Patient Relations
  • Linda Montella-Carter, Senior Vice President and Chief Information Officer
  • Eric Pauwels, Chief Business Officer
  • Hege Sollie-Zetlmayer, Chief Human Resources Officer
  • Christine Utter, Senior Vice President, Chief Accounting Officer and Head of People Services
  • Michael Schmertzler, Chairman
  • William F. Bell, Jr., Managing Director and Head of Healthcare Services Practice, L.E.K. Consulting
  • Allan Jacobson, Ph.D., University of Massachusetts Chan Medical School
  • Stephanie S. Okey, M.S., Former SVP, Head of North America, Rare Disease – Genzyme
  • Emma Reeve, Independent Board Director
  • Mary Smith, The VENG Group
  • David P. Southwell, Former CEO, TScan Therapeutics
  • Glenn D. Steele, Jr., M.D., Ph.D., Chairman, GSteele Health Solutions
  • Alethia Young, Chief Financial Officer, Bicycle Therapeutics
  • Jerome B. Zeldis, M.D., Ph.D., Independent Board Director

Last updated: 2024-12-31

Protagenic Therapeutics, Inc.

Protagenic Therapeutics, Inc. logo
Market Cap: Lowest
Employees: Lowest

PT00114

Protagenic Therapeutics, Inc. is a biopharmaceutical company focused on discovering and developing therapeutics for stress-related neuropsychiatric and mood disorders. Its lead compound, PT00114, aims to regulate stress response and restore healthy brain function.

Tags: biopharmaceutical, brain health, mood disorders, neuropsychiatric disorders, stress response, therapeutics

Symbol: PTIX

Recent Price: $0.54

Industry: Biotechnology

CEO: Dr. Garo H. Armen Ph.D.

Sector: Healthcare

Employees: 1

Address: 149 Fifth Avenue, New York, NY 10010

Phone: 212 994 8200

Last updated: 2024-12-31

Petros Pharmaceuticals, Inc.

Petros Pharmaceuticals, Inc. logo
Market Cap: Lowest
Employees: Lowest

Stendra

Petros Pharmaceuticals, Inc. is a pharmaceutical company that focuses on men's health therapeutics, including the commercialization and development of Stendra, a PDE-5 inhibitor for erectile dysfunction, and H100 for Peyronie's disease.

Tags: Erectile Dysfunction, Men's Health, Peyronie's Disease, Pharmaceuticals, Stendra

Symbol: PTPI

Recent Price: $0.31

Industry: Drug Manufacturers - Specialty & Generic

CEO: Mr. Fady Boctor M.B.A.

Sector: Healthcare

Employees: 21

Address: 1185 Avenue of the Americas, New York, NY 10036

Phone: 973-242-0005

Last updated: 2024-11-08

Silo Pharma, Inc.

Silo Pharma, Inc. logo
Market Cap: Lowest
Employees: Lowest

SPC-15

Silo Pharma Inc. is a developmental stage biopharmaceutical company focusing on treatments for stress-induced psychiatric disorders, chronic pain, and CNS diseases through traditional and psychedelic therapies.

Tags: CNS diseases, biopharmaceutical, chronic pain, psychedelic treatments, psychiatric disorders, traditional therapies

Symbol: SILO

Recent Price: $0.89

Industry: Biotechnology

CEO: Mr. Eric Weisblum

Sector: Healthcare

Employees: 3

Address: 677 N. Washington Boulevard, Sarasota, FL 34236

Phone: 718 400 9031

Last updated: 2024-12-31

Verastem, Inc.

Verastem, Inc. logo
Market Cap: Low
Employees: Low

VS-6766

Verastem, Inc. is a biopharmaceutical company focused on developing and commercializing drugs for cancer treatment, with products such as VS-6766 and trials like RAMP 201 and 202 targeting various cancer types.

Tags: MEK, RAF, RAMP 201, RAMP 202, VS-6766, biopharmaceutical, cancer treatment, drug development

Symbol: VSTM

Recent Price: $3.67

Industry: Biotechnology

CEO: Mr. Daniel W. Paterson

Sector: Healthcare

Employees: 73

Address: 117 Kendrick Street, Needham, MA 02494

Phone: 781 292 4200

Last updated: 2024-12-31

Fennec Pharmaceuticals Inc.

Fennec Pharmaceuticals Inc. logo
Market Cap: Low
Employees: Lowest

PEDMARK

Fennec Pharmaceuticals Inc. is a biopharmaceutical company focused on developing PEDMARK, a sodium thiosulfate formulation for preventing platinum-induced ototoxicity in pediatric cancer patients. The company, formerly known as Adherex Technologies Inc., is based in Research Triangle Park, North Carolina and was incorporated in 1996.

Tags: PEDMARK, biopharmaceutical, ototoxicity, pediatric cancer, sodium thiosulfate

Symbol: FENC

Recent Price: $6.16

Industry: Biotechnology

CEO: Mr. Rostislav Raykov

Sector: Healthcare

Employees: 29

Address: 68 TW Alexander Drive, Research Triangle Park, NC 27709

Phone: 919 636 4530

Last updated: 2024-12-31

Eagle Pharmaceuticals, Inc.

Eagle Pharmaceuticals, Inc. logo
Market Cap: Lowest
Employees: Low

Ryanodex, Belrapzo, Bendeka, EP-4104, PEMFEXY, EA-114, Vasopressin

Eagle Pharmaceuticals, Inc. specializes in the development and commercialization of pharmaceutical products targeting diseases of the central nervous system, metabolic critical care, and oncology in the U.S. Notable products include Ryanodex for malignant hyperthermia, and oncology treatments Belrapzo and Bendeka.

Tags: antitoxin, central nervous system, collaboration agreements, critical care, disease treatment, oncology, pharmaceutical

Symbol: EGRX

Recent Price: $0.50

Industry: Drug Manufacturers - Specialty & Generic

CEO: Mr. Michael Graves

Sector: Healthcare

Employees: 134

Address: 50 Tice Boulevard, Woodcliff Lake, NJ 07677

Phone: 201 326 5300

Last updated: 2024-12-31

Nuvectis Pharma, Inc.

Nuvectis Pharma, Inc. logo
Market Cap: Low
Employees: Lowest

NXP800, NXP900

Nuvectis Pharma, Inc., is a biopharmaceutical company that focuses on developing precision medicines for treating serious unmet medical needs in oncology. It is working on products like NXP800, a heat shock factor 1 pathway inhibitor, and NXP900, a drug candidate targeting Proto-oncogene c-Src and YES1 kinases.

Tags: NXP800, NXP900, biopharmaceutical, oncology, precision medicine

Symbol: NVCT

Recent Price: $5.14

Industry: Biotechnology

CEO: Mr. Ron Bentsur M.B.A.

Sector: Healthcare

Employees: 13

Address: 1 Bridge Plaza, Fort Lee, NJ 07024

Phone: 201 614 3150

Last updated: 2024-12-31